In the wake of the increase in Current Liabilities in the third quarter 2024, Quick Ratio fell to 9.38 a new company low.

Within Laboratory Analytical Instruments industry 3 other companies have achieved higher Quick Ratio than Singular Genomics Systems Inc in third quarter 2024. While Quick Ratio total ranking in the third quarter 2024 has deteriorated compared to the prior quarter from 218 to 301.

Explain Quick Ratio?
How much Cash & cash equivalents OMIC�s has?
What are OMIC�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OMIC Quick Ratio	(Sep 30 2024) Q3	(Jun 30 2024) Q2	(Mar 31 2024) Q1	(Dec 31 2023) Q4	(Sep 30 2023) Q3
Y / Y Current Liabilities Change	56.71 %	55.79 %	49.1 %	35 %	-8.59 %
Y / Y Cash & cash equivalent Change	-40.31 %	-35.55 %	-33.32 %	-28.88 %	-27.71 %
Quick Ratio MRQ	9.38	13.48	18.26	16.53	24.62
OMIC's Total Ranking	# 301	# 218	# 144	# 170	# 98
Seq. Current Liabilities Change	22.85 %	19.68 %	-21.53 %	35.83 %	22.13 %
Seq. Cash & cash equivalent Change	-14.54 %	-11.63 %	-13.34 %	-8.8 %	-7.72 %

Quick Ratio third quarter 2024 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 4
Healthcare Sector	# 154
Overall Market	# 301

Quick Ratio Statistics
High	Average	Low
59.59	32.74	9.38
(Sep 30 2021)		(Sep 30 2024)

Financial Statements
Singular Genomics Systems Inc 's Current Liabilities	$ 12 Millions	Visit OMIC's Balance sheet
Singular Genomics Systems Inc 's Cash & cash equivalent	$ 114 Millions	Visit OMIC's Balance sheet
Source of OMIC's Sales		Visit OMIC's Sales by Geography

Cumulative Singular Genomics Systems Inc 's Quick Ratio

OMIC's Quick Ratio for the trailling 12 Months

OMIC Quick Ratio	(Sep 30 2024) 12 Months	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months	(Sep 30 2023) 12 Months
Y / Y Current Liabilities TTM Growth	48.79 %	29.33 %	10 %	-2.04 %	-10.36 %
Y / Y Cash & cash equivalent TTM Growth	-34.14 %	-31.09 %	-29.35 %	-28.28 %	-28.05 %
Quick Ratio TTM	14.01	17.81	21.97	26.45	31.65
Total Ranking TTM	# 3050	# 2868	# 2816	# 2789	# 2979
Seq. Current Liabilities TTM Growth	12.07 %	10.77 %	9.02 %	9.95 %	-2.59 %
Seq. Cash & cash equivalent TTM Growth	-11.85 %	-10.18 %	-9.45 %	-8.14 %	-7.77 %

Quick ratio ranking by company, industry and sector >> Back to OMIC Financial Strength Comparisons >> Go to Compare OMIC Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q3 2024 to $12.14 millions, cumulative Quick Ratio decreased to 14.01 below the Singular Genomics Systems Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 23 other companies have achieved higher Quick Ratio than Singular Genomics Systems Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2024 from 2868 to 3050.

Explain Quick Ratio?
How much Cash & cash equivalents OMIC�s has?
What are OMIC�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 24
Healthcare Sector	# 892
Within the Market	# 3050

trailing twelve months Quick Ratio Statistics
High	Average	Low
46.18	22.15	8.3
(Mar 31 2022)		(Sep 30 2024)

Companies with similar Quick Ratio in the quarter ending Sep 30 2024, within Laboratory Analytical Instruments Industry	Quick Ratio	Sep 30 2024 MRQ Cash & cash equivalent	Sep 30 2024 MRQ Current Liabilities
Seer Inc	17.21	$ 247.600 Millions	$ 14.383 Millions
Nautilus Biotechnology Inc	16.23	$ 140.609 Millions	$ 8.662 Millions
Astrotech Corp	13.31	$ 28.308 Millions	$ 2.127 Millions
Pacific Biosciences Of California Inc	10.69	$ 471.147 Millions	$ 44.080 Millions
Singular Genomics Systems Inc	9.38	$ 113.833 Millions	$ 12.140 Millions
Quanterix Corporation	8.05	$ 293.523 Millions	$ 36.454 Millions
Reflect Scientific Inc	7.40	$ 1.030 Millions	$ 0.139 Millions
Rapid Micro Biosystems Inc	6.47	$ 60.832 Millions	$ 9.402 Millions
Eyepoint Inc	5.30	$ 258.693 Millions	$ 48.794 Millions
Bio rad Laboratories Inc	5.14	$ 1,628.018 Millions	$ 316.985 Millions
Cytek Biosciences Inc	4.42	$ 277.777 Millions	$ 62.797 Millions
10x Genomics Inc	4.00	$ 398.159 Millions	$ 99.600 Millions
Standard Biotools Inc	3.04	$ 366.330 Millions	$ 120.615 Millions

Date modified: 2026-09-08T15:11:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.